May 11, 2026 · Form 4 insider transaction
Ridloff Elena sold 3,000 shares of Kymera Therapeutics, Inc. at $87.00 per share, a transaction worth $261.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.